|
Volumn 32, Issue 10, 2012, Pages 3315-3317
|
Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab
|
Author keywords
Adalimumab*Drug induced lupus; Etanercept; Rheumatoid arthritis; Rituximab
|
Indexed keywords
ADALIMUMAB;
ANTINUCLEAR ANTIBODY;
COMPLEMENT COMPONENT C3;
COMPLEMENT COMPONENT C4;
DNA ANTIBODY;
ETANERCEPT;
HYDROXYCHLOROQUINE;
LEFLUNOMIDE;
METHOTREXATE;
METHYLPREDNISOLONE;
PREDNISOLONE;
RHEUMATOID FACTOR;
RITUXIMAB;
RO ANTIBODY;
SALAZOSULFAPYRIDINE;
ADULT;
ALOPECIA;
ANEMIA;
ANOREXIA;
ARTHRALGIA;
ARTICLE;
CASE REPORT;
DISEASE ACTIVITY;
DISEASE CONTROL;
DRUG WITHDRAWAL;
DRY EYE;
FEMALE;
FEVER;
HUMAN;
LEUKOPENIA;
LUPUS LIKE SYNDROME;
LYMPHOCYTOPENIA;
MALAISE;
PRIORITY JOURNAL;
PROTEINURIA;
RAYNAUD PHENOMENON;
REMISSION;
RHEUMATOID ARTHRITIS;
RHEUMATOID NODULE;
STEROID THERAPY;
TREATMENT RESPONSE;
URTICARIA;
VASCULITIS;
WEIGHT REDUCTION;
ADULT;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DRUG SUBSTITUTION;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MIDDLE AGED;
RECEPTORS, TUMOR NECROSIS FACTOR;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84867898748
PISSN: 01728172
EISSN: 1437160X
Source Type: Journal
DOI: 10.1007/s00296-011-2137-y Document Type: Article |
Times cited : (17)
|
References (7)
|